JB Chemicals and Pharmaceuticals Ltd.

BSE: 506943 | NSE: JBCHEPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE572A01036 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

JB Chemicals a JB Chemicals and Pharmaceuticals Ltd. | BSE 1702.90 -4.00 (-0.23%) | NSE 1702.20 -6.60 (-0.39%) | Trade | Add

BSE Live

Oct 24, 16:01

1702.90 -4.00 (-0.23%)

Volume

AVERAGE VOLUME

5-Day

7,103

10-Day

4,498

30-Day

2,665

835

Prev. Close

1706.90
Open Price

1724.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Oct 24, 15:55

1702.20 -6.60 (-0.39%)

Volume

AVERAGE VOLUME

5-Day

112,729

10-Day

136,785

30-Day

146,946

95,512

Prev. Close

1708.80
Open Price

1721.50

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1702.20 (131)

Financials

Print/Copy to Excel : Go

Profit & Loss account of JB Chemicals and Pharmaceuticals (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	3,867.12	3,449.08	3,120.91	2,397.62	2,002.11
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	3,867.12	3,449.08	3,120.91	2,397.62	2,002.11
Total Operating Revenues	3,917.99	3,484.18	3,149.28	2,424.24	2,042.52
Other Income	38.32	37.27	9.94	39.23	112.38
Total Revenue	3,956.31	3,521.45	3,159.22	2,463.47	2,154.90
EXPENSES
Cost Of Materials Consumed	820.03	816.28	783.98	602.22	542.39
Purchase Of Stock-In Trade	496.95	412.62	395.22	258.16	200.37
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FGWIP And Stock In Trade	-0.43	-46.85	-11.00	-17.45	-41.26
Employee Benefit Expenses	687.61	601.41	543.45	439.24	340.60
Finance Costs	11.73	44.33	36.05	5.12	7.24
Depreciation And Amortisation Expenses	171.04	138.32	114.41	72.66	68.67
Other Expenses	881.99	803.83	741.88	598.61	440.01
Total Expenses	3,068.92	2,769.94	2,603.99	1,958.57	1,558.02
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	887.39	751.51	555.23	504.90	596.89
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	887.39	751.51	555.23	504.90	596.89
Tax Expenses-Continued Operations
Current Tax	202.42	150.62	89.31	128.15	142.20
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	27.39	47.86	55.92	-9.29	6.16
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	227.81	198.88	145.23	118.86	148.36
Profit/Loss After Tax And Before ExtraOrdinary Items	659.58	552.63	410.01	386.04	448.52
Profit/Loss From Continuing Operations	659.58	552.63	410.01	386.04	448.52
Profit/Loss For The Period	659.58	552.63	410.01	386.04	448.52
Minority Interest	0.00	0.00	-0.17	-0.68	-0.56
Consolidated Profit/Loss After MI And Associates	659.58	552.63	409.84	385.36	447.96
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	42.00	36.00	53.00	50.00	58.00
Diluted EPS (Rs.)	42.00	35.00	52.00	50.00	58.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	237.04	156.99	127.59	127.52	73.42
Tax On Dividend	0.00	0.00	0.00	0.00	0.00